This work highlights the synthesis of a series of novel chalcone derivatives as anticancer agents. Screening the target compounds against the human breast tumor cell line (MCF-7) and human carcinoma (HepG2) was carried out. Percentage inhibition of tubulin beta depolymerization was measure for representative target compounds. Eleven out of nineteen target compounds showed broad spectrum antitumor activity.